Answers are grounded in this paper and cite their sources.
Clinical trial shows changes in immune cell populations post-treatment in patients with metastatic melanoma, suggesting potential vaccine efficacy.
Supplementary Figure S5. Aggregate cell densities are shown for five patients with pre-and post-treatment biopsies assayed by multiplex immunofluorescence (mIF) for markers of CD4+, CD8+, CD68+, CD11c and SOX10+ PD-L1+ cells (accompanying individual patient data shown in Figure 4). Analyses of changes in mIF were based on random effects, mixed models using an autoregressive covariance structure for within-patient variability. Differences between pre- and post-treatment were estimated using contrasts within the model. P-values shown are nominal.
No takes yet. Share an insight, caveat, or question.
Hodi et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: